Transition to Non-Proprietary Medical Corporations: Options Before and After M&A and Inheritance Tax Measures

Transitioning from a proprietary medical corporation to a non-proprietary one in the future is a significant strategic option for directors, considering inheritance tax measures and M&A (mergers and acquisitions). Specifically, transitioning to a fund-contribution type corporation or a social medical corporation can offer multifaceted benefits such as maintaining corporate status, facilitating business succession, and contributing to regional healthcare. This article provides an easy-to-understand explanation, based on expert knowledge, of the specific steps involved in transitioning from a proprietary to a non-proprietary medical corporation, the merits and demerits of such a transition, and its relationship with M&A and inheritance tax measures. As an estimate of the potential reduction in inheritance tax burden through this transition, generally, tax savings ranging from tens of millions to hundreds of millions of yen can be expected in some cases. However, this varies greatly depending on the corporation’s size, asset status, and the chosen transition scheme, making detailed simulations tailored to individual circumstances essential.

What is the Transition to a Non-Proprietary Medical Corporation? Its Purpose and Benefits

Transitioning to a non-proprietary medical corporation refers to a change in corporate structure where, upon dissolution or merger, the remaining assets are attributed to the national government, local public bodies, or other medical corporations. In proprietary medical corporations, members (shareholders) have a proprietary interest in the corporation’s assets and can distribute assets according to their share upon dissolution. However, in non-proprietary medical corporations, members do not hold direct property rights in the corporation, and the residual assets upon dissolution are returned to society in a manner that ensures non-profitability.

The main objectives of this transition are as follows:

• Inheritance Tax Measures: Proprietary interests in proprietary medical corporations are considered inherited assets and can be subject to high inheritance taxes. By transitioning to a non-proprietary corporation, these proprietary interests are excluded from the inherited assets, significantly reducing the inheritance tax burden.
• Facilitation of Business Succession: If proprietary interests are dispersed through inheritance, it can lead to succession issues and disputes over management rights. Becoming a non-proprietary corporation prevents the concentration of assets in specific individuals, enabling smoother business succession.
• Response to M&A (Mergers and Acquisitions): Non-proprietary corporations, focusing on social contribution rather than profit, tend to have smoother valuations and negotiations during M&A. They also find it easier to obtain public certifications such as Social Medical Corporation or Specified Medical Corporation, increasing opportunities for management stabilization and new business development.
• Ensuring Non-Profit Status and Promoting Social Contribution: This clarifies the inherent non-profit nature of medical corporations and encourages a focus on contributing to regional healthcare and engaging in highly public-interest activities.

Main Schemes and Procedural Flow for Transitioning to a Non-Proprietary Corporation

The main schemes for transitioning to a non-proprietary medical corporation include the following. The choice of scheme should be determined by comprehensively considering the corporation’s current status, future vision, and tax and legal implications.

1. Transition to a Fund-Contribution Type Corporation

In this type, assets contributed by members (shareholders) of a proprietary medical corporation are contributed to the corporation as a “fund,” and the members only hold the right to claim repayment of this fund. The fund becomes the corporation’s asset, and members hold the status of creditors to the corporation. This effectively makes inheritance or transfer of proprietary interests impossible, serving as an inheritance tax and business succession measure.

2. Transition to a Social Medical Corporation

This is a status that a non-proprietary medical corporation meeting certain requirements (e.g., contribution to regional healthcare, provision of emergency medical services) can obtain through certification by the prefectural governor. While eligible for preferential tax treatment (e.g., exemption from corporate and fixed asset taxes), it requires stricter operational management. From an M&A perspective, it enhances social credibility and is expected to play a central role in regional healthcare collaboration.

3. Merger/Acquisition by Other Medical Corporations, etc. (Becoming a Non-Proprietary Corporation)

This involves a proprietary medical corporation merging with another medical corporation that is already a non-proprietary corporation, or transferring its business to such a corporation. In this case, the proprietary medical corporation is dissolved, and its assets are attributed to the merged medical corporation.

【General Flow of Transition Procedures】

1. Development of Transition Plan: Detailed consideration of the transition objectives, chosen scheme, schedule, and impacts of the transition (tax, financial, personnel, etc.).
2. Resolution at General Meeting of Members: Obtain approval for the transition plan at the general meeting of members.
3. Consultation and Application for Approval with Supervisory Authority (Prefecture, etc.): Depending on the transition scheme, conduct preliminary consultations with the relevant supervisory authority and submit the necessary approval application.
4. Registration and Notifications, etc.: Complete change registration at the Legal Affairs Bureau and submit various notifications to the tax office, social insurance institutions, etc.
5. Execution of Transition: Execute procedures such as fund contribution, merger, or dissolution based on the plan.

Coordination with M&A and Inheritance Tax Measures

The transition to a non-proprietary medical corporation is closely related to M&A and inheritance tax measures. For directors facing these issues, the transition can be a highly effective solution.

Impact on M&A

In M&A of proprietary medical corporations, the valuation of proprietary interests significantly impacts the acquisition price. Transitioning to a non-proprietary corporation can simplify the calculation of the acquisition price and potentially lead to smoother negotiations. Furthermore, transitioning to a social medical corporation or similar entity can enhance valuation during M&A from the perspective of public contribution to regional healthcare. When considering future M&A, becoming a non-proprietary corporation at an early stage can be a strategic choice.

Effectiveness as Inheritance Tax Measures

Proprietary interests in proprietary medical corporations are evaluated as deemed inherited assets under inheritance tax law. Their valuation is calculated based on the corporation’s net assets and earning capacity, often resulting in high figures. By transitioning to a non-proprietary corporation, these proprietary interests subject to valuation disappear, significantly compressing the assets subject to inheritance tax. For example, if a medical corporation’s net assets are in the hundreds of millions of yen, inheritance tax can be reduced by tens of millions to over one hundred million yen in some cases through the transition. However, depending on the timing and method of transition, gift tax or income tax may arise, making tax simulations by experts indispensable.

Comparison Item	Proprietary Medical Corporation	Fund-Contribution Type Corporation	Social Medical Corporation
Attribution of Residual Assets	Attributed to members (shareholders)	Only the right to claim repayment to members (fund contributors)	To the national government, local public bodies, other medical corporations, etc. (for social contribution purposes)
Inheritance Tax Measures	Proprietary interests are subject to taxation	Proprietary interests extinguished, reducing inheritance tax burden	Proprietary interests extinguished, reducing inheritance tax burden
Impact on M&A	Valuation of proprietary interests is complex, affecting negotiations	No valuation of proprietary interests needed, negotiations are smoother	Public nature is easily valued, negotiations are smoother
Tax Preferential Treatment	Limited	Fund interest is deductible	Exemptions for corporate tax, fixed asset tax, etc.

Points to Consider When Considering a Transition and the Importance of Consulting Experts

While transitioning to a non-proprietary medical corporation offers many benefits, it requires careful consideration. The transition process is complex and has wide-ranging impacts on tax, legal, financial, and organizational operations.

【Points to Note】

• Transition Costs: Certain costs are incurred, including fees for experts and various procedural expenses.
• Impact on Corporate Operations: In fund-contribution type and social medical corporations, operational rules change, potentially affecting the roles of directors and officers, decision-making processes, etc.
• Tax Risks: There is a non-zero risk of unintended gift tax or income tax arising during the transition. In particular, errors in asset valuation or procedural deficiencies increase the risk of tax audits.
• Difficulty of Social Medical Corporation Certification: Strict requirements are set for social medical corporation certification, and not everyone can be certified.

To avoid these risks and achieve an optimal transition, consulting with experts (lawyers, tax accountants, consultants, etc.) specializing in medical M&A and reorganization of medical corporations is essential. Experts can accurately analyze your corporation’s current situation, propose the optimal scheme aligned with your future vision, handle complex procedures on your behalf, and implement measures to mitigate potential risks.

Frequently Asked Questions

Q1: How are the proprietary interests of a proprietary medical corporation specifically valued for inheritance tax purposes?

A1: The inheritance tax valuation of proprietary interests is primarily conducted based on the Basic Notice for Property Valuation under the Inheritance Tax Act. Based on the corporation’s net assets (total assets minus liabilities), the valuation of individual proprietary interests is calculated considering factors such as the number of members and contribution ratios. Depending on the valuation method, the value may be significantly higher than the book value.

Q2: Does transitioning to a fund-contribution type corporation disadvantage M&A?

A2: On the contrary, it often proves advantageous. In fund-contribution type corporations, since members’ proprietary interests are extinguished, the calculation of the acquisition price during M&A becomes clearer, facilitating smoother negotiations. Furthermore, maintaining the corporate status ensures business continuity.

Q3: How long does it take to transition to a social medical corporation?

A3: Transitioning to a social medical corporation often takes more than a year due to the preparation period required to meet the criteria and the prefectural governor’s certification review process. Early preparation and planned operations to meet the certification requirements are crucial.

Q4: Is it possible to handle the transition procedures on our own?

A4: It is extremely difficult to handle the procedures alone, as specialized knowledge of law and taxation is essential, and the procedures are complex. It is strongly recommended to engage experts (lawyers, tax accountants, M&A consultants, etc.). Experts will provide advice tailored to your corporation’s situation and support the smooth execution of procedures.

📊 FREE ASSESSMENT

1-Minute, 3-Question Free Simple Assessment

We will provide an estimated transfer value for your medical institution on the spot.
Strictly confidential, no sales calls, receive report via email.

Start Free Simple Assessment →